Clinical Development, Early Access Programs and Clinical Trial Supply
Total Trials
3
As Lead Sponsor
0
As Collaborator
Total Enrollment
74
NCT03252847
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)
Phase: Phase 1/2
Role: Collaborator
Start: Jul 31, 2017
Completion: Nov 18, 2021
NCT03343327
A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects
Phase: Phase 1
Start: Feb 19, 2018
Completion: Apr 20, 2018
Loading map...